Preventative Treatment of Bronchopulmonary Dysplasia (BPD)PNEUMOSTEM®
PNEUMOSTEM® is under-development for the preventive treatment of Bronchopulmonary Dysplasia (BPD) for premature infants. It is based on Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cells.
PNEUMOSTEM® successfully completed Phase 2 clinical trial in Korea and its administration in Phase 1/2 (FDA IND) clinical trial in the U.S. Orphan Drug Designation was granted in the U.S. and E.U.Further researches for expanding indications to the various adult lung diseases are also in progress
5 Days After